Vistagen Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-7.3M | $-7.5M | $239.1K | — |
| FY2018 | $-9.1M | $-9.1M | $1.6K | — |
| FY2019 | $-14.5M | $-14.7M | $174.0K | — |
| FY2020 | $-15.8M | $-15.8M | $0 | — |
| FY2021 | $-12.1M | $-12.3M | $275.4K | $2.3M |
| FY2022 | $-45.3M | $-45.5M | $200.4K | $3.5M |
| FY2023 | $-49.7M | $-50.2M | $528.0K | $3.3M |
| FY2024 | $-25.8M | $-25.8M | $0 | $2.2M |
| FY2025 | $-42.1M | $-42.1M | — | $4.3M |
| FY2026 | $-66.4M | $-66.4M | — | $4.0M |